Sinopharm Group Co Stock Technical Analysis

SHTDF Stock  USD 2.70  0.35  14.89%   
As of the 28th of February, Sinopharm Group has the Coefficient Of Variation of 1771.48, risk adjusted performance of 0.0496, and Variance of 4.46. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sinopharm Group, as well as the relationship between them. Please validate Sinopharm Group market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Sinopharm Group is priced more or less accurately, providing market reflects its prevalent price of 2.7 per share. Please also confirm Sinopharm Group Co information ratio, which is currently at 0.0139 to double-check the company can sustain itself at a future point.

Sinopharm Group Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sinopharm, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Sinopharm
  
Sinopharm Group's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Sinopharm Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sinopharm Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sinopharm Group's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Sinopharm Group 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinopharm Group's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinopharm Group.
0.00
11/30/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/28/2026
0.00
If you would invest  0.00  in Sinopharm Group on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Sinopharm Group Co or generate 0.0% return on investment in Sinopharm Group over 90 days. Sinopharm Group is related to or competes with Matsumotokiyoshi, Sysmex Corp, Sonic Healthcare, Sonic Healthcare, Guangzhou Baiyunshan, ConvaTec Group, and Getinge Industrier. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and heal... More

Sinopharm Group Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinopharm Group's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinopharm Group Co upside and downside potential and time the market with a certain degree of confidence.

Sinopharm Group Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinopharm Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinopharm Group's standard deviation. In reality, there are many statistical measures that can use Sinopharm Group historical prices to predict the future Sinopharm Group's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinopharm Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.502.704.90
Details
Intrinsic
Valuation
LowRealHigh
0.412.614.81
Details
Naive
Forecast
LowNextHigh
0.632.835.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-4.392.612.96
Details

Sinopharm Group February 28, 2026 Technical Indicators

Sinopharm Group Backtested Returns

At this point, Sinopharm Group is relatively risky. Sinopharm Group owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0587, which indicates the firm had a 0.0587 % return per unit of risk over the last 3 months. We have found twenty technical indicators for Sinopharm Group Co, which you can use to evaluate the volatility of the company. Please validate Sinopharm Group's Coefficient Of Variation of 1771.48, variance of 4.46, and Risk Adjusted Performance of 0.0496 to confirm if the risk estimate we provide is consistent with the expected return of 0.13%. Sinopharm Group has a performance score of 4 on a scale of 0 to 100. The entity has a beta of -0.0815, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sinopharm Group are expected to decrease at a much lower rate. During the bear market, Sinopharm Group is likely to outperform the market. Sinopharm Group right now has a risk of 2.2%. Please validate Sinopharm Group jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Sinopharm Group will be following its existing price patterns.

Auto-correlation

    
  -0.52  

Good reverse predictability

Sinopharm Group Co has good reverse predictability. Overlapping area represents the amount of predictability between Sinopharm Group time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinopharm Group price movement. The serial correlation of -0.52 indicates that about 52.0% of current Sinopharm Group price fluctuation can be explain by its past prices.
Correlation Coefficient-0.52
Spearman Rank Test-0.03
Residual Average0.0
Price Variance0.02
Sinopharm Group technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Sinopharm Group technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sinopharm Group trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Sinopharm Group Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Sinopharm Group across different markets.

About Sinopharm Group Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sinopharm Group Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sinopharm Group Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sinopharm Group price pattern first instead of the macroeconomic environment surrounding Sinopharm Group. By analyzing Sinopharm Group's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sinopharm Group's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sinopharm Group specific price patterns or momentum indicators. Please read more on our technical analysis page.

Sinopharm Group February 28, 2026 Technical Indicators

Most technical analysis of Sinopharm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sinopharm from various momentum indicators to cycle indicators. When you analyze Sinopharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Sinopharm Group February 28, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sinopharm stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Sinopharm Pink Sheet analysis

When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities